Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

MEHLMAN CONSULTING, INC. for BETTER LIFE HEALTH, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income

MEHLMAN CONSULTING, INC. for BLUE CROSS BLUE SHIELD MICHIGAN

1st Quarter (Jan 1 - Mar 31) 2026 · Michigan · House · Senate · $40,000.00 income

Medicare/Medicaid, Pharmacy, Insurance, Taxation/Internal Revenue Code

MEHLMAN CONSULTING, INC. for BLUE SHIELD OF CALIFORNIA

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income

Health Issues, Pharmacy, Medicare/Medicaid

SQUIRE PATTON BOGGS for ASCENSUS SPECIALTIES LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Washington · House · Senate · $200,000.00 income

Chemicals/Chemical Industry, Defense, Foreign Relations, Pharmacy

P STREET PROJECT, INC. for P STREET PROJECT, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Government Issues, Labor Issues/Antitrust/Workplace, Agriculture, Consumer Issues/Safety/Products

FORBES-TATE for CALIFORNIA LIFE SCIENCES ASSOCIATION

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $40,000.00 income

Health Issues, Manufacturing, Medical/Disease Research/Clinical Labs, Medicare/Medicaid

RUBIN, TURNBULL & ASSOCIATES for ASSOCIATION FOR ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $150,000.00 income

Pharmacy, Health Issues

DA VINCI GROUP for PROCARE, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $20,000.00 income

DA VINCI GROUP for BOESEN & SNOW, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Arizona · House · Senate · $10,000.00 income

VAN SCOYOC ASSOCIATES for QUVA PHARMA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $50,000.00 income

RUBIN, TURNBULL & ASSOCIATES for PHRMA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $90,000.00 income

Pharmacy, Health Issues

RUBIN, TURNBULL & ASSOCIATES for USANTIBIOTICS

1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · $90,000.00 income

VAN SCOYOC ASSOCIATES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $70,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy

S-3 GROUP for GOODRX

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income

Pharmacy, Health Issues

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy, Trade (domestic/foreign)

LMH STRATEGIC SOLUTIONS for TRAVERE THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · $30,000.00 income

LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income

Health Issues, Pharmacy

LMH STRATEGIC SOLUTIONS for SAVARA INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $60,000.00 income

Pharmacy, Health Issues

LMH STRATEGIC SOLUTIONS for REGENXBIO INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $60,000.00 income

Pharmacy, Health Issues

LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income

Medicare/Medicaid, Pharmacy

LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $50,000.00 income

Pharmacy, Health Issues

LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Pharmacy

LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income

Medicare/Medicaid, Pharmacy

CORNERSTONE GOVERNMENT AFFAIRS, INC. for DALLAS COUNTY HOSPITAL DISTRICT D/B/A PARKLAND HEALTH

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $30,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy

LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS, PLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000.00 income

Previous Page 10 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem